AU3080192A - Peroral administration form for peptidic medicaments, in particular insulin - Google Patents

Peroral administration form for peptidic medicaments, in particular insulin

Info

Publication number
AU3080192A
AU3080192A AU30801/92A AU3080192A AU3080192A AU 3080192 A AU3080192 A AU 3080192A AU 30801/92 A AU30801/92 A AU 30801/92A AU 3080192 A AU3080192 A AU 3080192A AU 3080192 A AU3080192 A AU 3080192A
Authority
AU
Australia
Prior art keywords
peptidic
administration form
peroral administration
gelatine
particular insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU30801/92A
Other versions
AU671964B2 (en
Inventor
Jurgen Freidenreich
Ursula Schick
Jurgen Werry
Jens-Christian Wunderlich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfatec Pharma GmbH
Original Assignee
Alfatec Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19914140178 external-priority patent/DE4140178C2/en
Priority claimed from DE19914140177 external-priority patent/DE4140177C2/en
Priority claimed from DE19914140195 external-priority patent/DE4140195C2/en
Priority claimed from DE19914140186 external-priority patent/DE4140186C2/en
Application filed by Alfatec Pharma GmbH filed Critical Alfatec Pharma GmbH
Publication of AU3080192A publication Critical patent/AU3080192A/en
Application granted granted Critical
Publication of AU671964B2 publication Critical patent/AU671964B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00—Photosensitive materials
    • G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/04—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
    • G03C1/047—Proteins, e.g. gelatine derivatives; Hydrolysis or extraction products of proteins
    • G03C2001/0471—Isoelectric point of gelatine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A peroral administration form for peptidic medicaments contains the peptidic medicament, in particular insulin, distributed in a gelatine or gelatine derivate matrix, besides usual pharmaceutical excipients and additives. By selecting an appropriate gelatine, the medicament is released in the small or large intestine, so that it is no longer enzymatically decomposed by peptidases.
AU30801/92A 1991-12-05 1992-12-04 Peroral administration form for peptidic medicaments, in particular insulin Ceased AU671964B2 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
DE19914140178 DE4140178C2 (en) 1991-12-05 1991-12-05 Acute form for a medicament containing indolylacetic acid derivative and its preparation
DE4140186 1991-12-05
DE4140178 1991-12-05
DE19914140177 DE4140177C2 (en) 1991-12-05 1991-12-05 Nanosol acute form for glibenclamide
DE4140177 1991-12-05
DE19914140195 DE4140195C2 (en) 1991-12-05 1991-12-05 Pharmaceutical nanosol and process for its manufacture
DE4140195 1991-12-05
DE19914140186 DE4140186C2 (en) 1991-12-05 1991-12-05 Peroral application form for peptide drugs, especially insulin
US87686792A 1992-04-30 1992-04-30
US876867 1992-04-30
PCT/DE1992/001009 WO1993010767A1 (en) 1991-12-05 1992-12-04 Peroral administration form for peptidic medicaments, in particular insulin

Publications (2)

Publication Number Publication Date
AU3080192A true AU3080192A (en) 1993-06-28
AU671964B2 AU671964B2 (en) 1996-09-19

Family

ID=27511568

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30801/92A Ceased AU671964B2 (en) 1991-12-05 1992-12-04 Peroral administration form for peptidic medicaments, in particular insulin

Country Status (9)

Country Link
EP (1) EP0615444B1 (en)
AT (1) ATE134875T1 (en)
AU (1) AU671964B2 (en)
CA (1) CA2125284C (en)
DE (1) DE59205625D1 (en)
DK (1) DK0615444T3 (en)
ES (1) ES2085656T3 (en)
GR (1) GR3019608T3 (en)
WO (1) WO1993010767A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018374A1 (en) * 1998-10-01 2000-04-06 Elan Pharma International, Ltd. Controlled release nanoparticulate compositions
DK1165119T3 (en) 1999-04-08 2003-12-15 Genentech Inc Composition based on oppositely charged polypeptides
DE19951617A1 (en) * 1999-10-26 2001-05-03 Basf Ag Preparations of active pharmaceutical ingredients
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
CN108309955B (en) * 2018-04-27 2020-06-02 武昌理工学院 Preparation method of polygeline-conjugated paclitaxel nanoparticles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
JPS5911563B2 (en) * 1980-02-27 1984-03-16 日本原子力研究所 Method for manufacturing multilayer sustained release composites
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
EP0179904A1 (en) * 1984-05-09 1986-05-07 Medaphore Inc. Oral insulin and a method of making the same
DE3684446D1 (en) * 1985-12-28 1992-04-23 Sumitomo Pharma MEDICINAL PRODUCTS WITH DELAYED RELEASED RELEASE.
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system

Also Published As

Publication number Publication date
DK0615444T3 (en) 1996-07-08
EP0615444B1 (en) 1996-03-06
ES2085656T3 (en) 1996-06-01
GR3019608T3 (en) 1996-07-31
ATE134875T1 (en) 1996-03-15
EP0615444A1 (en) 1994-09-21
DE59205625D1 (en) 1996-04-11
AU671964B2 (en) 1996-09-19
WO1993010767A1 (en) 1993-06-10
CA2125284C (en) 2000-06-20
CA2125284A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
FI944035A (en) Tramadol salt-containing drug with delayed release of the active substance
MY111879A (en) Pharmaceutical formulations.
NO930604L (en) DOSAGE FORM FOR MEDICINAL DELIVERY WITH DIFFERENT PATTERNS
ES2171431T3 (en) PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE.
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
WO1994027589A3 (en) Antidepressant dosage form
IL129410A0 (en) A unit dose sustained-release oral dosage form
MY119722A (en) Swallow tablet comprising paracetamol.
ES2010466A6 (en) Effervescent tablet containing diclofenac
AU3080192A (en) Peroral administration form for peptidic medicaments, in particular insulin
KR950013513A (en) Moenomycin and its derivatives for the manufacture of a medicament, and a medicament containing moenomycin or its derivatives
ES2191241T3 (en) PHARMACEUTICAL PREPARATIONS BY ORAL ROUTE THAT INCLUDE S- (3-HYDROXIPROPIL) -L-CISTEINE.
DE69120536D1 (en) DRUG
KR920019365A (en) Pharmaceutical Formulations Containing Dirithromycin
DK0615439T3 (en) Iburprofen-containing retard drug and its use
ES2184121T3 (en) FORMULATION FOR THE TREATMENT AND / OR PROFILAXIS OF DEMENTIA.
IT1243343B (en) Liquid pharmaceutical composition for nasal administration containing a polypeptide as active substance
AU3080692A (en) Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation
RU2002101613A (en) A method for the correction of immuno-and hepatotoxic effects of cyclophosphamide